Functional Genetics
Gaithersburg, Maryland, United StatesPurpose
to develop a novel HIV vaccine strategy based on antibody targeting of a host protein, TSG101, selectively expressed on HIV-infected cells, using a concept with borader potential to prevent other viral infections
Grantee
Division
Global Health
Date
NOVEMBER 2009
Region served
GLOBAL
Committed amount
$736,114
Grant topic
HIV
Duration (months)
14
Grantee location
Gaithersburg, Maryland, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.